A. Subramanian

发表

Therapies for Long COVID in non-hospitalised individuals - from symptoms, patient-reported outcomes, and immunology to targeted therapies (The TLC Study): Study protocol

C. Frost, E. Sapey, A. Denniston, 2021, medRxiv.

Maternal and children's outcomes for pregnant women with pre-existing multiple long-term conditions: a study protocol of an observational study in the United Kingdom

M. Singh, A. Azcoaga-Lorenzo, S. Thangaratinam, 2022, medRxiv.

The Incidence of Immune Mediated Inflammatory Diseases Following COVID-19: a Matched Cohort Study in UK Primary Care

K. Nirantharakumar, S. Haroon, K. McGee, 2022, medRxiv.

The effect of SARS-CoV-2 variant on respiratory features and mortality

Y. Huang, N. Lambert, R. Chakraborty, 2022, Scientific Reports.

Shared within-host SARS-CoV-2 variation in households

M. Holubar, P. Jagannathan, C. Khosla, 2022, medRxiv.

Development and validation of the Symptom Burden Questionnaireâ¢ for Long COVID: a Rasch analysis

C. Frost, O. Aiyegbusi, G. Turner, 2022, medRxiv.

The cost of primary care consultations associated with long COVID in non-hospitalised patients: a retrospective cohort study using UK primary care data

S. Haroon, K. Gokhale, T. Williams, 2023, medRxiv.

Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole

A. Subramanian, J. Ballon, H. Bonilla, 2021, Journal of translational medicine.

Survivors of SARS-CoV-2 Infection Show Neuropsychiatric Sequelae Measured by Surveys, Neurocognitive Testing, and Magnetic Resonance Imaging: Preliminary Results

M. Wintermark, M. Chesnut, P. Grant, 2021, medRxiv.